2009 Oct 22 – Use of Ribavirin to Treat Influenza

Volume 361:1713-1714 October 22, 2009 Number 17
To the Editor: Ribavirin, an antiviral drug with in vitro activity against both DNA and RNA viruses, is approved in the United States for the treatment of hepatitis C and respiratory syncytial virus.1 Hepatitis C is treated with approved oral formulations in combination with interferon products; respiratory syncytial virus is treated with an aerosol formulation. Intravenous ribavirin is not currently approved in the United States.


Weblink here